Oxford University malaria vaccine first to meet WHO efficacy goal

When asked if this was the most effective malaria vaccine in the world, Prof Hill said: “It is in the sense that no other vaccine has had a primary endpoint with over 75% efficacy, yes."

Professor Adrian Hill said researchers hoped to report the results of the final stage of the trial next year. Picture: John Cairns/University of Oxford/PA

Researchers in Britain have developed the world’s most effective malaria vaccine, with it becoming the first to achieve the World Health Organisation-specified 75% efficacy goal.

Researchers from the University of Oxford and their partners have reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated 77% efficacy over 12 months of follow-up.